Orzalesi N, Fossarello M, Sorcinelli R, Schlich U
Doc Ophthalmol. 1984 May 30;57(3):187-201. doi: 10.1007/BF00143083.
The Italian island of Sardina occupies an important position on the map of glucose-6-phosphate dehydrogenase (G6PD)-deficiency distribution throughout the world, since in this region the condition is particularly frequent and severe (erythrocytes show only 0-7% of G6PD normal activity, while people result affect up to 35% depending on the district). In order to investigate the relationship between the deficiency of G6PD in erythrocytes and in lens, and cataractogenesis, we studied 2125 idiopathic cataractous and non-cataractous subjects, both G6PD-deficient and normal, males and females. Parameters investigated included incidence, distribution and type of cataracts, age at the moment of the first observation, geographical provenance, and G6PD activity in erythrocytes. Moreover, G6PD activity and glutathione (GSSG)-reducing activity was assessed in cataractous lenses obtained from deficient and normal individuals. G6PD deficiency was found to be significantly more frequent in males of the age-group 40-49 years (P = 0.025), while the frequency of G6PD deficiency was decisively lower in the older age-groups. In females, mainly heterozygotes, no evidence of such a relation was found. Cataractous lenses obtained from male patients with no G6PD activity in erythrocytes showed undetectable levels of G6PD activity, and lowered, but not extinguished, levels of GSSG-reducing activity. Cataractous lenses from heterozygous females showed intermediate levels of G6PD activity and GSSG-reducing activity. A preliminary study of 182 diabetic, G6PD-deficient and non-deficient subjects, failed to demonstrate that Sardinian variants of G6PD deficiency provide protection against cataract formation in diabetic patients.
意大利的撒丁岛在全球葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症分布图上占据重要位置,因为在该地区这种病症尤为常见且严重(红细胞仅显示出G6PD正常活性的0-7%,而根据不同地区,受影响的人群比例高达35%)。为了研究红细胞和晶状体中G6PD缺乏与白内障形成之间的关系,我们对2125名特发性白内障和非白内障患者进行了研究,这些患者既有G6PD缺乏者也有正常者,涵盖男性和女性。研究的参数包括白内障的发病率、分布和类型、首次观察时的年龄、地理来源以及红细胞中的G6PD活性。此外,还评估了从G6PD缺乏和正常个体获取的白内障晶状体中的G6PD活性和谷胱甘肽(GSSG)还原活性。结果发现,40-49岁年龄组的男性中G6PD缺乏症明显更为常见(P = 0.025),而在年龄较大的组中G6PD缺乏症的发生率则明显较低。在女性中,主要是杂合子,未发现这种关系的证据。从红细胞中无G6PD活性的男性患者获取的白内障晶状体显示G6PD活性检测不到,且GSSG还原活性水平降低但未完全消失。杂合子女性的白内障晶状体显示G6PD活性和GSSG还原活性处于中间水平。对182名糖尿病患者、G6PD缺乏和非缺乏患者的初步研究未能证明撒丁岛型G6PD缺乏变异对糖尿病患者的白内障形成具有保护作用。